Skip to main content
. 2024 Apr 6;193(4):1749–1753. doi: 10.1007/s11845-024-03676-8

Table 2.

Association of post-diagnosis regular and non-regular supplement use with attitudes and perceptions

Attitudes & Perceptions Post diagnosis regular users
N (%)
Post diagnosis non-regular users
N (%)
p-value 95% CI
Dietary supplement use and risk of developing breast cancer Increases risk 1 (0.5) 5 (2.7) 0.016 0.013-0.018
No effect on risk 26 (14.1) 26 (14.1)
Decreases risk 14 (7.6) 5 (2.7)
Uncertain/Do not know 43 (23.2) 65 (35.1)
Dietary supplement use and risk of breast cancer recurrence Increases risk 1 (0.5) 9 (4.9) 0.000 0.000<0.001
No effect on risk 20 (10.8) 19 (10.3)
Decreases risk 18 (9.7) 4 (2.2)
Uncertain/Do not know 45 (24.3) 69 (37.3)
Dietary supplement use and risk of breast cancer-related mortality Increases risk 0 (0) 4 (2.2) 0.014 0.012-0.017
No effect on risk 26 (14.1) 21 (11.4)
Decreases risk 14 (7.6) 8 (4.3)
Uncertain/Do not know 44 (23.8) 68 (36.8)
Dietary supplement use is safe during cancer treatments Agree 33 (17.8) 23 (12.4) 0.033 0.029-0.037
Disagree 12 (6.5) 25 (13.5)
Uncertain/Do not know 39 (21.1) 53 (28.6)
Dietary supplement use is safe after the completion of cancer treatments Agree 47 (25.4) 43 (23.2) 0.186 0.178-0.193
Disagree 3 (1.6) 4 (2.2)
Uncertain/Do not know 34 (18.4) 54 (29.2)
Dietary supplements increase the effectiveness of cancer treatments Agree 15 (8.1) 7 (3.8) 0.052 0.047-0.056
Disagree 12 (6.5) 21 (11.4)
Uncertain/Do not know 57 (30.8) 73 (39.5)
Dietary supplements reduce the side effects of cancer treatments Agree 16 (8.6) 12 (6.5) 0.314 0.305-0.323
Disagree 18 (9.7) 19 (10.3)
Uncertain/Do not know 50 (27) 70 (37.8)
It is important to inform healthcare providers about the dietary supplements I am taking Agree 68 (36.8) 87 (47) 0.421 0.411-0.430
Disagree 1 (0.5) 0 (0)
Uncertain/Do not know 15 (8.1) 14 (7.6)
I would like more information on dietary supplements Agree 68 (36.8) 72 (38.9) 0.176 -
Disagree 15 (8.1) 26 (14.1)

CI confidence interval